Review



fty720  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    MedChemExpress fty720
    Recruitment of circulating lymphocytes is a major source of lung CD4 + T RM cells in BLM-induced PF. ( A ) Schematic diagram of the mouse treatment schedule. <t>FTY720</t> (1 mg/kg) or PBS was administered intraperitoneally once daily from 3 days before (D-3) to 14 days after (D14) BLM-induced PF. ( B ) Representative flow cytometry plots of CD3 + CD8 − (CD4 + ) and CD3 + CD8 + T cell frequencies among peripheral blood CD45 + cells in both groups, taken 1 day before (D-1) BLM administration. ( C ) Quantitative analysis of CD3 + CD4 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups at D-1. n = 6 in FTY720 group, and n = 5 in Vehicle group. ( D ) Quantitative analysis of CD3 + CD8 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups at D-1. n = 6 in FTY720 group, and n = 5 in Vehicle group. ( E ) Representative flow cytometry plots showing the proportions of CD3 + CD4 + and CD3 + CD8 + T cells among peripheral blood CD45 + cells in both groups on D14. ( F ) Quantitative analysis of CD3 + CD4 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups on D14. n = 6 for each group. ( G ) Quantitative analysis of CD3 + CD8 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups on D14. n = 6 for each group. ( H ) Representative contour plots of CD3 and CD8 expression in lung CD45 + T cells. (I–L) The absolute numbers of CD4 + T cells ( I ), CD8 + T cells ( J ), CD4 + non-T RM cells ( K ) and CD4 + CD69 + CD103 + T RM cells ( L ) in the lung were measured by flow cytometry. n = 6 for each group. Data were expressed as mean ± SEM. Student’s t test panel ( C , D , F , G , I – L ). *** p < 0.001, **** p < 0.0001.
    Fty720, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 65 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fty720/product/MedChemExpress
    Average 95 stars, based on 65 article reviews
    fty720 - by Bioz Stars, 2026-03
    95/100 stars

    Images

    1) Product Images from "Notch Signaling Exacerbates Pulmonary Fibrosis by Regulating the Differentiation of CD4 + Tissue-Resident Memory T Cells"

    Article Title: Notch Signaling Exacerbates Pulmonary Fibrosis by Regulating the Differentiation of CD4 + Tissue-Resident Memory T Cells

    Journal: Biomolecules

    doi: 10.3390/biom16020328

    Recruitment of circulating lymphocytes is a major source of lung CD4 + T RM cells in BLM-induced PF. ( A ) Schematic diagram of the mouse treatment schedule. FTY720 (1 mg/kg) or PBS was administered intraperitoneally once daily from 3 days before (D-3) to 14 days after (D14) BLM-induced PF. ( B ) Representative flow cytometry plots of CD3 + CD8 − (CD4 + ) and CD3 + CD8 + T cell frequencies among peripheral blood CD45 + cells in both groups, taken 1 day before (D-1) BLM administration. ( C ) Quantitative analysis of CD3 + CD4 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups at D-1. n = 6 in FTY720 group, and n = 5 in Vehicle group. ( D ) Quantitative analysis of CD3 + CD8 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups at D-1. n = 6 in FTY720 group, and n = 5 in Vehicle group. ( E ) Representative flow cytometry plots showing the proportions of CD3 + CD4 + and CD3 + CD8 + T cells among peripheral blood CD45 + cells in both groups on D14. ( F ) Quantitative analysis of CD3 + CD4 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups on D14. n = 6 for each group. ( G ) Quantitative analysis of CD3 + CD8 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups on D14. n = 6 for each group. ( H ) Representative contour plots of CD3 and CD8 expression in lung CD45 + T cells. (I–L) The absolute numbers of CD4 + T cells ( I ), CD8 + T cells ( J ), CD4 + non-T RM cells ( K ) and CD4 + CD69 + CD103 + T RM cells ( L ) in the lung were measured by flow cytometry. n = 6 for each group. Data were expressed as mean ± SEM. Student’s t test panel ( C , D , F , G , I – L ). *** p < 0.001, **** p < 0.0001.
    Figure Legend Snippet: Recruitment of circulating lymphocytes is a major source of lung CD4 + T RM cells in BLM-induced PF. ( A ) Schematic diagram of the mouse treatment schedule. FTY720 (1 mg/kg) or PBS was administered intraperitoneally once daily from 3 days before (D-3) to 14 days after (D14) BLM-induced PF. ( B ) Representative flow cytometry plots of CD3 + CD8 − (CD4 + ) and CD3 + CD8 + T cell frequencies among peripheral blood CD45 + cells in both groups, taken 1 day before (D-1) BLM administration. ( C ) Quantitative analysis of CD3 + CD4 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups at D-1. n = 6 in FTY720 group, and n = 5 in Vehicle group. ( D ) Quantitative analysis of CD3 + CD8 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups at D-1. n = 6 in FTY720 group, and n = 5 in Vehicle group. ( E ) Representative flow cytometry plots showing the proportions of CD3 + CD4 + and CD3 + CD8 + T cells among peripheral blood CD45 + cells in both groups on D14. ( F ) Quantitative analysis of CD3 + CD4 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups on D14. n = 6 for each group. ( G ) Quantitative analysis of CD3 + CD8 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups on D14. n = 6 for each group. ( H ) Representative contour plots of CD3 and CD8 expression in lung CD45 + T cells. (I–L) The absolute numbers of CD4 + T cells ( I ), CD8 + T cells ( J ), CD4 + non-T RM cells ( K ) and CD4 + CD69 + CD103 + T RM cells ( L ) in the lung were measured by flow cytometry. n = 6 for each group. Data were expressed as mean ± SEM. Student’s t test panel ( C , D , F , G , I – L ). *** p < 0.001, **** p < 0.0001.

    Techniques Used: Flow Cytometry, Expressing

    Inhibition of the recruitment of circulating lymphocytes alleviated BLM-induced PF. ( A ) Schematic diagram of the mouse treatment schedule. FTY720 (1 mg/kg) or PBS was administered intraperitoneally once daily from 3 days before (D-3) to 14 days after (D14) BLM-induced PF. n = 6 for each group. ( B ) Body weight loss was monitored daily. ( C ) Mouse lung images. ( D ) Mouse lung index. ( E , F ) H&E staining of lung sections ( E ) and Ashcroft scores ( F ) from the two groups of mice. ( G , H ) Masson staining of lung sections ( G ) and collagen volume fraction ( H ) in the two groups. ( I , J ) Immunohistochemistry staining for α-SMA in lung sections ( I ) and quantitative analysis of its integrated optical density (IOD) ( J ) in the two groups. ( K ) Fibrosis marker expressions were detected by qPCR. Data were expressed as mean ± SEM. Student’s t test panel ( B , D , F , H , J , K ). * p < 0.05, ** p < 0.01, ns: not significant.
    Figure Legend Snippet: Inhibition of the recruitment of circulating lymphocytes alleviated BLM-induced PF. ( A ) Schematic diagram of the mouse treatment schedule. FTY720 (1 mg/kg) or PBS was administered intraperitoneally once daily from 3 days before (D-3) to 14 days after (D14) BLM-induced PF. n = 6 for each group. ( B ) Body weight loss was monitored daily. ( C ) Mouse lung images. ( D ) Mouse lung index. ( E , F ) H&E staining of lung sections ( E ) and Ashcroft scores ( F ) from the two groups of mice. ( G , H ) Masson staining of lung sections ( G ) and collagen volume fraction ( H ) in the two groups. ( I , J ) Immunohistochemistry staining for α-SMA in lung sections ( I ) and quantitative analysis of its integrated optical density (IOD) ( J ) in the two groups. ( K ) Fibrosis marker expressions were detected by qPCR. Data were expressed as mean ± SEM. Student’s t test panel ( B , D , F , H , J , K ). * p < 0.05, ** p < 0.01, ns: not significant.

    Techniques Used: Inhibition, Staining, Immunohistochemistry, Marker



    Similar Products

    95
    MedChemExpress fty720
    Recruitment of circulating lymphocytes is a major source of lung CD4 + T RM cells in BLM-induced PF. ( A ) Schematic diagram of the mouse treatment schedule. <t>FTY720</t> (1 mg/kg) or PBS was administered intraperitoneally once daily from 3 days before (D-3) to 14 days after (D14) BLM-induced PF. ( B ) Representative flow cytometry plots of CD3 + CD8 − (CD4 + ) and CD3 + CD8 + T cell frequencies among peripheral blood CD45 + cells in both groups, taken 1 day before (D-1) BLM administration. ( C ) Quantitative analysis of CD3 + CD4 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups at D-1. n = 6 in FTY720 group, and n = 5 in Vehicle group. ( D ) Quantitative analysis of CD3 + CD8 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups at D-1. n = 6 in FTY720 group, and n = 5 in Vehicle group. ( E ) Representative flow cytometry plots showing the proportions of CD3 + CD4 + and CD3 + CD8 + T cells among peripheral blood CD45 + cells in both groups on D14. ( F ) Quantitative analysis of CD3 + CD4 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups on D14. n = 6 for each group. ( G ) Quantitative analysis of CD3 + CD8 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups on D14. n = 6 for each group. ( H ) Representative contour plots of CD3 and CD8 expression in lung CD45 + T cells. (I–L) The absolute numbers of CD4 + T cells ( I ), CD8 + T cells ( J ), CD4 + non-T RM cells ( K ) and CD4 + CD69 + CD103 + T RM cells ( L ) in the lung were measured by flow cytometry. n = 6 for each group. Data were expressed as mean ± SEM. Student’s t test panel ( C , D , F , G , I – L ). *** p < 0.001, **** p < 0.0001.
    Fty720, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fty720/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    fty720 - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    94
    MedChemExpress fingolimod fty720 hydrochloride
    Recruitment of circulating lymphocytes is a major source of lung CD4 + T RM cells in BLM-induced PF. ( A ) Schematic diagram of the mouse treatment schedule. <t>FTY720</t> (1 mg/kg) or PBS was administered intraperitoneally once daily from 3 days before (D-3) to 14 days after (D14) BLM-induced PF. ( B ) Representative flow cytometry plots of CD3 + CD8 − (CD4 + ) and CD3 + CD8 + T cell frequencies among peripheral blood CD45 + cells in both groups, taken 1 day before (D-1) BLM administration. ( C ) Quantitative analysis of CD3 + CD4 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups at D-1. n = 6 in FTY720 group, and n = 5 in Vehicle group. ( D ) Quantitative analysis of CD3 + CD8 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups at D-1. n = 6 in FTY720 group, and n = 5 in Vehicle group. ( E ) Representative flow cytometry plots showing the proportions of CD3 + CD4 + and CD3 + CD8 + T cells among peripheral blood CD45 + cells in both groups on D14. ( F ) Quantitative analysis of CD3 + CD4 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups on D14. n = 6 for each group. ( G ) Quantitative analysis of CD3 + CD8 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups on D14. n = 6 for each group. ( H ) Representative contour plots of CD3 and CD8 expression in lung CD45 + T cells. (I–L) The absolute numbers of CD4 + T cells ( I ), CD8 + T cells ( J ), CD4 + non-T RM cells ( K ) and CD4 + CD69 + CD103 + T RM cells ( L ) in the lung were measured by flow cytometry. n = 6 for each group. Data were expressed as mean ± SEM. Student’s t test panel ( C , D , F , G , I – L ). *** p < 0.001, **** p < 0.0001.
    Fingolimod Fty720 Hydrochloride, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fingolimod fty720 hydrochloride/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    fingolimod fty720 hydrochloride - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress hy 15382
    Recruitment of circulating lymphocytes is a major source of lung CD4 + T RM cells in BLM-induced PF. ( A ) Schematic diagram of the mouse treatment schedule. <t>FTY720</t> (1 mg/kg) or PBS was administered intraperitoneally once daily from 3 days before (D-3) to 14 days after (D14) BLM-induced PF. ( B ) Representative flow cytometry plots of CD3 + CD8 − (CD4 + ) and CD3 + CD8 + T cell frequencies among peripheral blood CD45 + cells in both groups, taken 1 day before (D-1) BLM administration. ( C ) Quantitative analysis of CD3 + CD4 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups at D-1. n = 6 in FTY720 group, and n = 5 in Vehicle group. ( D ) Quantitative analysis of CD3 + CD8 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups at D-1. n = 6 in FTY720 group, and n = 5 in Vehicle group. ( E ) Representative flow cytometry plots showing the proportions of CD3 + CD4 + and CD3 + CD8 + T cells among peripheral blood CD45 + cells in both groups on D14. ( F ) Quantitative analysis of CD3 + CD4 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups on D14. n = 6 for each group. ( G ) Quantitative analysis of CD3 + CD8 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups on D14. n = 6 for each group. ( H ) Representative contour plots of CD3 and CD8 expression in lung CD45 + T cells. (I–L) The absolute numbers of CD4 + T cells ( I ), CD8 + T cells ( J ), CD4 + non-T RM cells ( K ) and CD4 + CD69 + CD103 + T RM cells ( L ) in the lung were measured by flow cytometry. n = 6 for each group. Data were expressed as mean ± SEM. Student’s t test panel ( C , D , F , G , I – L ). *** p < 0.001, **** p < 0.0001.
    Hy 15382, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hy 15382/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    hy 15382 - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    95
    MedChemExpress fingolimod fty fty720 s phosphate
    Recruitment of circulating lymphocytes is a major source of lung CD4 + T RM cells in BLM-induced PF. ( A ) Schematic diagram of the mouse treatment schedule. <t>FTY720</t> (1 mg/kg) or PBS was administered intraperitoneally once daily from 3 days before (D-3) to 14 days after (D14) BLM-induced PF. ( B ) Representative flow cytometry plots of CD3 + CD8 − (CD4 + ) and CD3 + CD8 + T cell frequencies among peripheral blood CD45 + cells in both groups, taken 1 day before (D-1) BLM administration. ( C ) Quantitative analysis of CD3 + CD4 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups at D-1. n = 6 in FTY720 group, and n = 5 in Vehicle group. ( D ) Quantitative analysis of CD3 + CD8 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups at D-1. n = 6 in FTY720 group, and n = 5 in Vehicle group. ( E ) Representative flow cytometry plots showing the proportions of CD3 + CD4 + and CD3 + CD8 + T cells among peripheral blood CD45 + cells in both groups on D14. ( F ) Quantitative analysis of CD3 + CD4 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups on D14. n = 6 for each group. ( G ) Quantitative analysis of CD3 + CD8 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups on D14. n = 6 for each group. ( H ) Representative contour plots of CD3 and CD8 expression in lung CD45 + T cells. (I–L) The absolute numbers of CD4 + T cells ( I ), CD8 + T cells ( J ), CD4 + non-T RM cells ( K ) and CD4 + CD69 + CD103 + T RM cells ( L ) in the lung were measured by flow cytometry. n = 6 for each group. Data were expressed as mean ± SEM. Student’s t test panel ( C , D , F , G , I – L ). *** p < 0.001, **** p < 0.0001.
    Fingolimod Fty Fty720 S Phosphate, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fingolimod fty fty720 s phosphate/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    fingolimod fty fty720 s phosphate - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    95
    MedChemExpress fingolimod hydrochloride fty720
    (A) Indo fails to enhance CTX efficacy in immunodeficient NSG mice. The schema depicts the timeline of experimental procedures. NSG mice bearing established CT26 tumors (60–90 mm²) were randomized into four groups and treated as indicated. Tumor growth curves are shown. (B) Kaplan–Meier survival analysis of the same cohort. Data were pooled from two independent experiments. (C) The beneficial effect of Indo requires endogenous CD8⁺ T cells. The schema depicts the timeline of experimental procedures. BALB/c mice bearing established CT26 tumors (60–90 mm²) were treated with CTX+Indo. A subset of mice additionally received i.p. anti-CD8 Ab before and during treatment to deplete endogenous CD8⁺ T cells. Mice treated with CTX alone were included as controls. Tumor growth curves are shown. Mouse survival is summarized in the Kaplan-Meier plot (D). (E) Blockade of T cell trafficking by <t>FTY720</t> diminishes the efficacy of CTX+Indo. BALB/c mice with established CT26 tumors (60–90 mm²) were treated with CTX+Indo. These mice also received either FTY720 or solvent by i.p. injection three times weekly for 4 weeks, starting one day prior to CTX administration. Tumor growth curves are shown. (F) Kaplan–Meier survival analysis. Data were pooled from two independent experiments. Data were pooled from two independent experiments. Statistics: (B, D, F) Log-rank (Mantel-Cox) test. **, p < 0.01; ***, p < 0.001; ns, not significant.
    Fingolimod Hydrochloride Fty720, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fingolimod hydrochloride fty720/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    fingolimod hydrochloride fty720 - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    Image Search Results


    Recruitment of circulating lymphocytes is a major source of lung CD4 + T RM cells in BLM-induced PF. ( A ) Schematic diagram of the mouse treatment schedule. FTY720 (1 mg/kg) or PBS was administered intraperitoneally once daily from 3 days before (D-3) to 14 days after (D14) BLM-induced PF. ( B ) Representative flow cytometry plots of CD3 + CD8 − (CD4 + ) and CD3 + CD8 + T cell frequencies among peripheral blood CD45 + cells in both groups, taken 1 day before (D-1) BLM administration. ( C ) Quantitative analysis of CD3 + CD4 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups at D-1. n = 6 in FTY720 group, and n = 5 in Vehicle group. ( D ) Quantitative analysis of CD3 + CD8 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups at D-1. n = 6 in FTY720 group, and n = 5 in Vehicle group. ( E ) Representative flow cytometry plots showing the proportions of CD3 + CD4 + and CD3 + CD8 + T cells among peripheral blood CD45 + cells in both groups on D14. ( F ) Quantitative analysis of CD3 + CD4 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups on D14. n = 6 for each group. ( G ) Quantitative analysis of CD3 + CD8 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups on D14. n = 6 for each group. ( H ) Representative contour plots of CD3 and CD8 expression in lung CD45 + T cells. (I–L) The absolute numbers of CD4 + T cells ( I ), CD8 + T cells ( J ), CD4 + non-T RM cells ( K ) and CD4 + CD69 + CD103 + T RM cells ( L ) in the lung were measured by flow cytometry. n = 6 for each group. Data were expressed as mean ± SEM. Student’s t test panel ( C , D , F , G , I – L ). *** p < 0.001, **** p < 0.0001.

    Journal: Biomolecules

    Article Title: Notch Signaling Exacerbates Pulmonary Fibrosis by Regulating the Differentiation of CD4 + Tissue-Resident Memory T Cells

    doi: 10.3390/biom16020328

    Figure Lengend Snippet: Recruitment of circulating lymphocytes is a major source of lung CD4 + T RM cells in BLM-induced PF. ( A ) Schematic diagram of the mouse treatment schedule. FTY720 (1 mg/kg) or PBS was administered intraperitoneally once daily from 3 days before (D-3) to 14 days after (D14) BLM-induced PF. ( B ) Representative flow cytometry plots of CD3 + CD8 − (CD4 + ) and CD3 + CD8 + T cell frequencies among peripheral blood CD45 + cells in both groups, taken 1 day before (D-1) BLM administration. ( C ) Quantitative analysis of CD3 + CD4 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups at D-1. n = 6 in FTY720 group, and n = 5 in Vehicle group. ( D ) Quantitative analysis of CD3 + CD8 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups at D-1. n = 6 in FTY720 group, and n = 5 in Vehicle group. ( E ) Representative flow cytometry plots showing the proportions of CD3 + CD4 + and CD3 + CD8 + T cells among peripheral blood CD45 + cells in both groups on D14. ( F ) Quantitative analysis of CD3 + CD4 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups on D14. n = 6 for each group. ( G ) Quantitative analysis of CD3 + CD8 + T cell proportion and absolute number in peripheral blood CD45 + cells from both groups on D14. n = 6 for each group. ( H ) Representative contour plots of CD3 and CD8 expression in lung CD45 + T cells. (I–L) The absolute numbers of CD4 + T cells ( I ), CD8 + T cells ( J ), CD4 + non-T RM cells ( K ) and CD4 + CD69 + CD103 + T RM cells ( L ) in the lung were measured by flow cytometry. n = 6 for each group. Data were expressed as mean ± SEM. Student’s t test panel ( C , D , F , G , I – L ). *** p < 0.001, **** p < 0.0001.

    Article Snippet: To investigate the origin of lung T RM cells in PF, FTY720 (MCE, Monmouth Junction, NJ, USA, Cat#: HY-12005, 1 mg/kg) or vehicle was administered via intraperitoneal injection starting three days before BLM exposure and continued daily thereafter.

    Techniques: Flow Cytometry, Expressing

    Inhibition of the recruitment of circulating lymphocytes alleviated BLM-induced PF. ( A ) Schematic diagram of the mouse treatment schedule. FTY720 (1 mg/kg) or PBS was administered intraperitoneally once daily from 3 days before (D-3) to 14 days after (D14) BLM-induced PF. n = 6 for each group. ( B ) Body weight loss was monitored daily. ( C ) Mouse lung images. ( D ) Mouse lung index. ( E , F ) H&E staining of lung sections ( E ) and Ashcroft scores ( F ) from the two groups of mice. ( G , H ) Masson staining of lung sections ( G ) and collagen volume fraction ( H ) in the two groups. ( I , J ) Immunohistochemistry staining for α-SMA in lung sections ( I ) and quantitative analysis of its integrated optical density (IOD) ( J ) in the two groups. ( K ) Fibrosis marker expressions were detected by qPCR. Data were expressed as mean ± SEM. Student’s t test panel ( B , D , F , H , J , K ). * p < 0.05, ** p < 0.01, ns: not significant.

    Journal: Biomolecules

    Article Title: Notch Signaling Exacerbates Pulmonary Fibrosis by Regulating the Differentiation of CD4 + Tissue-Resident Memory T Cells

    doi: 10.3390/biom16020328

    Figure Lengend Snippet: Inhibition of the recruitment of circulating lymphocytes alleviated BLM-induced PF. ( A ) Schematic diagram of the mouse treatment schedule. FTY720 (1 mg/kg) or PBS was administered intraperitoneally once daily from 3 days before (D-3) to 14 days after (D14) BLM-induced PF. n = 6 for each group. ( B ) Body weight loss was monitored daily. ( C ) Mouse lung images. ( D ) Mouse lung index. ( E , F ) H&E staining of lung sections ( E ) and Ashcroft scores ( F ) from the two groups of mice. ( G , H ) Masson staining of lung sections ( G ) and collagen volume fraction ( H ) in the two groups. ( I , J ) Immunohistochemistry staining for α-SMA in lung sections ( I ) and quantitative analysis of its integrated optical density (IOD) ( J ) in the two groups. ( K ) Fibrosis marker expressions were detected by qPCR. Data were expressed as mean ± SEM. Student’s t test panel ( B , D , F , H , J , K ). * p < 0.05, ** p < 0.01, ns: not significant.

    Article Snippet: To investigate the origin of lung T RM cells in PF, FTY720 (MCE, Monmouth Junction, NJ, USA, Cat#: HY-12005, 1 mg/kg) or vehicle was administered via intraperitoneal injection starting three days before BLM exposure and continued daily thereafter.

    Techniques: Inhibition, Staining, Immunohistochemistry, Marker

    (A) Indo fails to enhance CTX efficacy in immunodeficient NSG mice. The schema depicts the timeline of experimental procedures. NSG mice bearing established CT26 tumors (60–90 mm²) were randomized into four groups and treated as indicated. Tumor growth curves are shown. (B) Kaplan–Meier survival analysis of the same cohort. Data were pooled from two independent experiments. (C) The beneficial effect of Indo requires endogenous CD8⁺ T cells. The schema depicts the timeline of experimental procedures. BALB/c mice bearing established CT26 tumors (60–90 mm²) were treated with CTX+Indo. A subset of mice additionally received i.p. anti-CD8 Ab before and during treatment to deplete endogenous CD8⁺ T cells. Mice treated with CTX alone were included as controls. Tumor growth curves are shown. Mouse survival is summarized in the Kaplan-Meier plot (D). (E) Blockade of T cell trafficking by FTY720 diminishes the efficacy of CTX+Indo. BALB/c mice with established CT26 tumors (60–90 mm²) were treated with CTX+Indo. These mice also received either FTY720 or solvent by i.p. injection three times weekly for 4 weeks, starting one day prior to CTX administration. Tumor growth curves are shown. (F) Kaplan–Meier survival analysis. Data were pooled from two independent experiments. Data were pooled from two independent experiments. Statistics: (B, D, F) Log-rank (Mantel-Cox) test. **, p < 0.01; ***, p < 0.001; ns, not significant.

    Journal: bioRxiv

    Article Title: Indomethacin exerts both cyclooxygenase inhibition-dependent and independent mechanisms to enhance chemo-immunotherapy in mice

    doi: 10.64898/2026.01.07.698231

    Figure Lengend Snippet: (A) Indo fails to enhance CTX efficacy in immunodeficient NSG mice. The schema depicts the timeline of experimental procedures. NSG mice bearing established CT26 tumors (60–90 mm²) were randomized into four groups and treated as indicated. Tumor growth curves are shown. (B) Kaplan–Meier survival analysis of the same cohort. Data were pooled from two independent experiments. (C) The beneficial effect of Indo requires endogenous CD8⁺ T cells. The schema depicts the timeline of experimental procedures. BALB/c mice bearing established CT26 tumors (60–90 mm²) were treated with CTX+Indo. A subset of mice additionally received i.p. anti-CD8 Ab before and during treatment to deplete endogenous CD8⁺ T cells. Mice treated with CTX alone were included as controls. Tumor growth curves are shown. Mouse survival is summarized in the Kaplan-Meier plot (D). (E) Blockade of T cell trafficking by FTY720 diminishes the efficacy of CTX+Indo. BALB/c mice with established CT26 tumors (60–90 mm²) were treated with CTX+Indo. These mice also received either FTY720 or solvent by i.p. injection three times weekly for 4 weeks, starting one day prior to CTX administration. Tumor growth curves are shown. (F) Kaplan–Meier survival analysis. Data were pooled from two independent experiments. Data were pooled from two independent experiments. Statistics: (B, D, F) Log-rank (Mantel-Cox) test. **, p < 0.01; ***, p < 0.001; ns, not significant.

    Article Snippet: Fingolimod hydrochloride (FTY720) was purchased from MedChemExpress.

    Techniques: Solvent, Injection

    (A) FTY720 administration reduces T cells in circulation but does not alter T cell frequency in secondary lymphoid organs. CT26-bearing BALB/c mice were treated as described in . A cohort of mice were euthanized after receiving 4 doses of FTY720 or solvent. The frequencies of CD4+ and CD8+ T cells in blood, draining lymph node and spleen were determined by flow cytometry. Representative dot plots are shown. Numbers in plots denote percent of CD4+ and CD8+ T cells. (B) FTY720 administration diminishes the efficacy of CTX+Indo in MC38 tumor model. Following the same experimental procedures depicted in , C57BL/6 mice with established MC38 tumors (60-90mm 2 ) were treated as indicated. Tumor growth curves are shown with mice numbers in each group indicated. Mouse survival is summarized in the Kaplan-Meier plot (C). Statistics: Log-rank (Mantel-Cox) test. *, p < 0.05; ns, not significant.

    Journal: bioRxiv

    Article Title: Indomethacin exerts both cyclooxygenase inhibition-dependent and independent mechanisms to enhance chemo-immunotherapy in mice

    doi: 10.64898/2026.01.07.698231

    Figure Lengend Snippet: (A) FTY720 administration reduces T cells in circulation but does not alter T cell frequency in secondary lymphoid organs. CT26-bearing BALB/c mice were treated as described in . A cohort of mice were euthanized after receiving 4 doses of FTY720 or solvent. The frequencies of CD4+ and CD8+ T cells in blood, draining lymph node and spleen were determined by flow cytometry. Representative dot plots are shown. Numbers in plots denote percent of CD4+ and CD8+ T cells. (B) FTY720 administration diminishes the efficacy of CTX+Indo in MC38 tumor model. Following the same experimental procedures depicted in , C57BL/6 mice with established MC38 tumors (60-90mm 2 ) were treated as indicated. Tumor growth curves are shown with mice numbers in each group indicated. Mouse survival is summarized in the Kaplan-Meier plot (C). Statistics: Log-rank (Mantel-Cox) test. *, p < 0.05; ns, not significant.

    Article Snippet: Fingolimod hydrochloride (FTY720) was purchased from MedChemExpress.

    Techniques: Solvent, Flow Cytometry